Infectious swine hepatitis E virus is present in pig manure storage facilities on United States farms, but evidence of water contamination is lacking by Kasorndorkbua, C. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infectious swine hepatitis E virus is present in pig manure
storage facilities on United States farms, but evidence of water
contamination is lacking
Citation for published version:
Kasorndorkbua, C, Opriessnig, T, Thomas, PJ, Halbur, PG, Huang, FF, Guenette, DK & Meng, X-J 2005,
'Infectious swine hepatitis E virus is present in pig manure storage facilities on United States farms, but
evidence of water contamination is lacking' Applied and Environmental Microbiology, vol. 71, no. 12, pp.
7831-7837. DOI: 10.1128/AEM.71.12.7831-7837.2005
Digital Object Identifier (DOI):
10.1128/AEM.71.12.7831-7837.2005
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Applied and Environmental Microbiology
Publisher Rights Statement:
Copyright © 2005, American Society for Microbiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Dec. 2005, p. 7831–7837 Vol. 71, No. 12
0099-2240/05/$08.000 doi:10.1128/AEM.71.12.7831–7837.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Infectious Swine Hepatitis E Virus Is Present in Pig Manure Storage
Facilities on United States Farms, but Evidence of
Water Contamination Is Lacking
C. Kasorndorkbua,1,2 T. Opriessnig,1 F. F. Huang,3 D. K. Guenette,3
P. J. Thomas,1 X.-J. Meng,3 and P. G. Halbur1*
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University,
Ames, Iowa 500111; Department of Veterinary Pathology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900,
Thailand2; and Center for Molecular Medicine and Infectious Diseases, College of Veterinary Medicine,
Virginia Polytechnic Institute and State University, Blacksburg, Virginia 240613
Received 7 December 2004/Accepted 10 August 2005
Fresh feces, manure slurry (from earthen lagoons and/or concrete pits), and drinking and surface water
samples were collected from 28 pig farms in the Midwestern United States. All samples were tested for hepatitis
E virus (HEV) RNA by reverse transcription-PCR. Seven of 28 farms had fecal samples that contained HEV.
Of 22 farms where pit samples were accessible, 15 contained HEV, and of 8 farms that had lagoons, 3 contained
HEV. The highest virus titers were 10 and 103 genome equivalents per 60 ml of manure slurry in lagoon and
pit samples, respectively. None of the water samples tested HEV positive. To determine the infectivity of the
HEV found in the positive farm 19 lagoon (designated L19) or farm 12 pit (designated P12) samples, pigs were
inoculated either intravenously (n  3) or orally (n  3) with the L19 or P12 manure slurry. Four pigs
inoculated intravenously with prototype swine HEV served as positive controls. All positive-control pigs shed
HEV in feces and 3 of 4 developed anti-HEV antibodies. Two pigs in the intravenously inoculated P12 group
shed HEV in feces, and one of the pigs seroconverted to anti-HEV antibodies. None of the pigs in the
negative-control, L19 oral, L19 intravenous, or P12 oral group shed HEV in feces. The findings indicate that
HEV found in pig manure slurry was infectious when inoculated intravenously. Pit manure slurry is a potential
source of HEV infection and for contamination of the environment. Contamination of drinking or surface water
with HEV was not found on or near the pig farms.
Hepatitis E virus (HEV) is the etiologic agent of an acute
self-limiting non-A, non-B hepatitis in humans (30). The virus
is a nonenveloped positive-sense single-stranded RNA virus
and was recently given taxonomic status in the genus of Hepe-
virus, a member of the family Hepeviridae (9). Human infection
with HEV typically manifests as acute icteric hepatitis. The
overall mortality is low, except for pregnant women, who may
suffer severe and fatal hepatitis with mortality rates up to 25%
(18, 19). HEV infection is distributed worldwide and is en-
demic to parts of Africa and Asia (18, 32).
Human HEV outbreaks in regions of endemicity are re-
portedly associated with flooding and heavy rains and spread
through the fecal-oral route of transmission (7, 8). HEV
infection in industrialized countries of nonendemicity is
sporadic and is often reported in human patients with a
history of traveling to countries of endemicity; however,
there are increasing cases of sporadic human HEV infection
in countries of nonendemicity such as Japan, Greece, Italy,
and the United States in patients without a history of trav-
eling to regions of endemicity. The human HEV discovered
in industrialized countries of nonendemicity appears to be
closely related to the swine HEV found in the same coun-
tries (4, 8, 28, 29, 31).
Pigs are a natural host for swine HEV (13, 25, 26). The
fecal-oral route is thought to be the primary mode of HEV
transmission (8, 36). Pigs infected with HEV shed the virus in
feces in large amounts for 3 to 4 weeks, whereas viremia is
transient and persists for 1 to 2 weeks (10, 15, 17). Current
pig-raising practices allow repeated exposure of pigs to feces
and thus to potentially high doses of HEV (17, 36).
Food-borne or blood transfusion routes have been impli-
cated as likely means of origin of sporadic cases of human
HEV infection in industrialized countries of nonendemicity
(20, 21, 33, 37). Genomic comparison of HEV from human
cases of sporadic acute or fulminant hepatitis E in Japan re-
vealed a high homology with swine HEV isolates found in pig
livers in nearby grocery stores, indicating that swine HEV in
inadequately cooked pig liver may be transmitted orally to
humans (37). Contamination of drinking or surface water in
the vicinity of pig production facilities is possible and of con-
cern (32). The status of HEV in pig manure slurry in storage
facilities such as concrete pits and earthen lagoons remains to
be investigated. If HEV is indeed present in stored pig manure
slurry, it needs to be determined if the virus is infectious to pigs
or other animals. The objectives of the present study were: (i)
to determine whether HEV is present in pig feces, stored
manure slurry, on-site drinking water supplies, and surface
water near swine production facilities and (ii) to determine if
HEV found in pig manure slurry and/or water samples is in-
fectious to naive pigs.
* Corresponding author. Mailing address: Department of Veterinary
Diagnostic and Production Animal Medicine, College of Veterinary Med-
icine, Iowa State University, Ames, IA 50011. Phone: (515) 294-1173. Fax:
(515) 294-1072. E-mail: pghalbur@iastate.edu.
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MATERIALS AND METHODS
Fecal sample collection and processing. In the late summer and autumn of
2002, 28 pig farms located in the Midwestern United States (Iowa) were visited
and sampled. Clinical evidence suggests that pigs in the United States most likely
become infected with swine HEV between 8 and 16 weeks of age (22, 25).
Because pig farms with various production styles were sampled, pigs of different
age groups ranging from newborns to adults were present on the 28 farms
(Table 1). Approximately 50 g of fresh feces from 5 live pigs ranging from 2 to 6
months of age (Table 1) were collected from the floor of the pig barns, pooled,
and prepared as a 10% (wt/vol) fecal suspension in diethyl pyrocarbonate
(DEPC) water-based phosphate-buffered saline (PBS).
Manure slurry sample collection and processing. Samples of manure slurry in
pits (22/28 farms had accessible pits) and lagoons (8/28 farms had lagoons) were
randomly obtained from each manure slurry storage facility and collected in a
50-ml sterile centrifuge tube. Ten manure slurry samples were collected from the
concrete pit under the slats of each finishing facility. The samples were taken
from 10 randomly selected sites in each pit. Each sample was collected from a
depth between 30 and 60 cm below the surface and directly below the pig pens.
For the lagoon manure slurry samples, 10 samples were randomly collected at a
depth of 120 and 200 cm under the surface crust.
All samples were transported on ice to the laboratory. The 10 tubes of each
manure slurry sample from each storage facility (pit and/or lagoon) were pooled
together in two aliquots of 250 ml. All fecal suspensions and manure slurry
samples were kept at 80°C until tested by reverse transcription (RT)-PCR
assay. Portions (60 ml) of the pooled manure slurry samples were subjected to
ultracentrifuge protocols to concentrate virus particles (27). The manure slurry
samples were clarified at 1,100  g for 10 min at 4°C. The supernatant was
ultracentrifuged at 229,600  g for 1 h at 4°C to pellet the virus particles. The
virus pellet was then diluted with 10 ml of 0.25 M glycine buffer (pH 9.4) on ice
for 30 min. The resuspended virus pellet was recentrifuged at 12,000  g for 15
min at 4°C to discard solid materials. The supernatant of the virus pellet was
saved and ultracentrifuged at 229,600  g for 1 h at 4°C to produce a final virus
concentrate. The final virus concentrate was resuspended with 400 l of DEPC
water-based PBS. Two aliquots of 200 l each were prepared for qualitative
nested RT-PCR and for semiquantitative nested RT-PCR and kept at 80°C
until tested. The manure slurry concentrate samples that were positive for HEV
RNA by the qualitative RT-PCR had their titers for HEV further determined by
the semiquantitative RT-PCR assay.
Water sample collection and processing. On each farm visited, 10 liters of
on-site drinking water and 10 liters of water from the nearest upstream and
downstream surface water (creeks, streams, or rivers) within a 0.4- to 6.4-kilo-
meter radius of the pig farms were collected and concentrated. All water samples
were collected in a sterile 10-liter container. Drinking water samples were di-
rectly obtained from a hydrant or faucet in or near the pig barns. Surface water
samples were directly collected from the water source by submerging the con-
tainer below the water surface. The water samples were transported in a cooler
with ice packs to the laboratory and were processed for virus concentration upon
arrival within a day of collection.
The concentration protocols were modified from those of Abbaszadegan et al.
(1) and the guidelines for detection of enteric viruses recommended by U.S.
Environmental Protection Agency (3). Water samples (10 liters) were run
through a sterile unit of a filter housing (CUNO, Inc., Meriden, CT) and car-
tridge (Virosorb MDS1; CUNO, Inc., Meriden, CT). All flowthrough water was
discarded. Once the filtering process was complete, 1 liter of autoclaved 0.25 M
glycine buffer (pH 9.4) was used to elute the entrapped virus particles in the filter
cartridge. The elution process was performed twice for 15 min. The first viral
TABLE 1. Detection of HEV RNA in pooled pig feces and environmental samples collected from 28 pig farms
Farm
identification no. Type of farm
a
Feces
Pit HEV RNA
(virus titer)b
Lagoon HEV RNA
(virus titer)bMean age of pigs
sampled (wk) HEV RNA
1 Farrow to finish 20 c  (103) NAd
2 Farrow 24   
3 Farrow to finish 16   
4 Farrow to finish 16   NA
5 Grow to finish 24   (10) NA
6 Grow to finish 20–24  NA 
7 Grow to finish 16   (10) NA
8 Grow to finish 12–16   NA
9 Grow to finish 16–20   (10) NA
10 Wean to finish 12    (10)
11 Farrow to finish 12   (10) NA
12 Grow to finish 20–24   (103) NA
13 Farrow to finish 20–24   (10) NA
14 Grow to finish 12–20   (10) NA
15 Grow to finish 8–20   (102) NA
16 Grow to finish 8   (10) NA
17 Farrow to finish 20–24  NA  (10)
18 Wean to finish 20   (10) NA
19 Farrow to finish 20  NA  (10)
20 Wean to finish 20–24   NA
21 Farrow to finish 16–20   (10) NA
22 Grow to finish 20   (10) NA
23 Farrow to finish 12–16  NA NA
24 Grow to finish 16–20  NA NA
25 Grow to finish 16–20   (102) 
26 Grow to finish 16–20   (102) NA
27 Grow to finish 16–20   NA
28 Wean to finish 16  NA 
Total 7/28 15/22 3/8
a Differences in the types of farms are due to the age groups of pigs present on the farm. Farrow (adults and newborn to 3-week-old piglets), farrow to finish (adults,
newborns, and pigs up to approximately 24 weeks of age), grow to finish (pigs from approximately 10 weeks to 24 weeks of age), wean to finish (pigs from weaning
[2 weeks] to market age, approximately 24 weeks).
b HEV genome titer is given as genome equivalents per 60 ml of manure slurry sample, determined by semi-qualitative RT-PCR.
c , negative for HEV RNA by qualitative RT-PCR; , positive for HEV RNA by qualitative RT-PCR.
d NA, sample not available at the farm.
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eluate was used for the second elution process. The final virus eluate was
neutralized at pH 7 to 7.4 with 1 N HCl (pH 1.5), mixed vigorously, and kept on
ice before proceeding to the virus concentration process by organic flocculation
(3). It has been suggested that HEV is relatively stable under acid and mildly
alkaline conditions (30), and previously, it has been confirmed that acidic pH
enhances the structure and stability of the HEV capsid protein (38). Therefore,
the neutralized virus eluate was adjusted to lower its pH to 3.5 with 1 N HCl and
12 g of autoclaved beef extract powder and stirred vigorously for 15 min. The
pH-adjusted virus eluate was then centrifuged at 3,000 g for 10 min at 4°C. The
supernatant of the virus eluate was discarded, and the resulting pellet was
resuspended with 50 ml of DEPC water-based PBS. The suspended virus pellet
was made into 2 aliquots of 25 ml. One aliquot was subjected to the centrifugal
concentration process to adjust the eluate volume for qualitative RT-PCR testing
and the other was kept at 80°C for an archival purpose. The virus eluate for
RT-PCR was subjected to 1,100  g for 20 min in a centrifugal filter unit
(Centricon; Millipore Corporation, Billerica, MA) to concentrate the eluate
volume for the RNA extraction steps.
To determine the sensitivity of the water concentration used in the present
study, 10 liters of tap water was spiked with 1 ml of a swine HEV infectious fecal
pool (10% wt/vol) with an HEV titer of 102 genome equivalents (GE) per ml
which resulted in a final concentration of 102 GE per ml water. The swine
HEV-spiked water was processed through the protocols described above.
Nested HEV RT-PCR. Hepatitis E virus is heterogenic in U.S. swine popula-
tions (13). To account for this, two different nested HEV RT-PCR approaches
were used (10, 13). Both PCR assays amplify portions of the ORF2 gene. The
universal nested RT-PCR assay designed to detect genetically variable strains of
HEV (13) was used to test the concentrated manure slurry (collected either from
concrete pit or earthen lagoon facilities) and concentrated water samples (col-
lected either from surface water sources or on-site drinking water), since the
extent of genetic variation among the HEV isolates was unknown. The U.S.
prototype nested RT-PCR assay designed to specifically detect the prototype
U.S. strain of swine HEV (10) was used in the bioassay due to 1-log-higher
sensitivity (13).
RNA isolation was similar for all samples and assays. The modified spin
column method (QIAamp; QIAGEN, Chatsworth, CA) was used to extract total
RNA from 140 l of concentrated manure slurry and water samples or fecal
suspensions (2). The RNA extract (11.5 l) was then immediately used for the
reverse transcription reaction for HEV cDNA synthesis.
For the universal nested RT-PCR, the first-round PCR primers were forward
primer 3156N (5-AATTATGCC[T]CAGTAC[T]CGG[A]GTTG-3) and re-
verse primer 3157N(5-CCCTTA[G]TCC[T]TGCTGA[C]GCATTCTC-3). The
second-round primers were the second forward primer 3158N (5-GTT[A]AT
GCTT[C]TGCATA[T]CATGGCT-3) and the second reverse primer 3159N
(5-AGCCGACGAAATCAATTCTGTC-3) (13). For the PCR parameters
used in the universal RT-PCRs, we strictly followed the protocol published by
Huang et al. (13). The second-round amplified PCR product of 348 bp in length
was visualized after 2% agarose gel electrophoresis.
For the U.S. prototype nested RT-PCR assay, the first-round PCR primers
were forward primer F1 (5-AGCTCCTGTACCTGATGTTGACTC-3) and re-
verse primer R1 (5-CTACAGAGCGCCAGCCTTGATTGC-3). The second-
round PCR primers were forward primer F2 (5-GCTCACGTCATCTGTCGC
TGCTGG-3) and reverse primer R2 (5-GGGCTGAACCAAAATCCTGAC
ATC-3) (10). To synthesize HEV cDNA, portions (11.5 l) of RNA extract
were amplified in a reverse transcription reaction with R1 reverse primer and
Superscript II reverse transcriptase (Invitrogen) at 42°C for 1 h. The cDNA (10
l) was used as a template in a 100-l PCR mixture. The first-round PCR was
initiated with the activation of AmpliTaq Gold DNA polymerase (Applied Bio-
systems) at 95°C for 9 min, followed by repeated 39 cycles of denaturation,
annealing, and extension at 94°C for 1 min, 52°C for 1 min, and 72°C for 1.5 min,
respectively, and finally, an incubation at 72°C for 7 min. Similar PCR para-
meters were applied to the second-round PCR. The second-round amplified
PCR product of 266 bp in length was visualized after 2% agarose gel electro-
phoresis.
Semiquantitative nested RT-PCR for titration of HEV. To determine the virus
titer in samples that tested positive for HEV RNA, serial 10-fold dilutions in
DEPC water-based PBS, ranging from 101 to 106 dilution, were made and
subjected to the universal RT-PCR. The virus titer was reported as GE at the
highest dilution found positive by the RT-PCR (23).
HEV genomic sequencing and phylogenetic analysis. PCR products amplified
from pooled feces and manure slurry were purified using the glass milk proce-
dure with a GENECLEAN kit (Bio 101, Inc., Carlsbad, CA) and then directly
sequenced at the Virginia Tech DNA Sequencing Facility. Sequences of the PCR
products were determined for both DNA strands. The primer sequences of the
universal RT-PCR were excluded from the sequence and phylogenetic analysis.
The resulting partial 222-bp sequences of positive feces and manure slurry were
analyzed and compared with the corresponding regions of prototype swine HEV
and some known strains of swine HEV available in the GenBank database by the
MacVector computer program (Oxford Molecular, Inc., Campbell, CA). Phylo-
genetic analysis was conducted with the aid of the PAUP program (David
Swofford, Smithsonian Institute, Washington, D.C., distributed by Sinauer As-
sociates, Inc., Sunderland, MA). A heuristic search with 1,000 replicates was used
to produce a phylogenetic tree. The geographic origins and the GenBank acces-
sion numbers of the nucleotide sequences of the HEV strains, representing four
major genotypes (8) and including the recently characterized avian HEV (11),
used in the phylogenetic and sequence analyses are as follows: human HEV
(hHEV) Sar-55 (Pakistan, accession no. M80851, genotype 1), hHEV Mexican
(Mexico, accession no. M74506, genotype 2), prototype swine HEV (United
States, accession no. AF082843, genotype 3), hHEV U.S.-2 (United States,
accession no. AF060669, genotype 3), hHEV T1 (China, accession no. AJ272108,
genotype 4), and avian HEV (United States, accession no. AY043166).
Virus inocula. The swine HEV inocula used for inoculation of the positive-
control pigs were prepared from an infectious stock of feces collected from pigs
intravenously infected with the prototype U.S. strain of swine HEV (25). The
inocula contained an HEV titer of 104.5 50% pig infectious doses per ml as
determined by intravenous inoculation, approximately equivalent to 106 GE per
ml (24). The inocula were kept at 80°C until used.
Swine bioassay. To determine if HEV RNA found in manure slurry samples
represented infectious virus particles, the HEV-positive pit and lagoon samples
with the highest titer of HEV measured by semiquantitative RT-PCR were
prepared as inocula for naive pigs in a swine bioassay. Nineteen 6-week-old,
specific-pathogen-free pigs were randomly separated into 6 groups of 3 to 4 pigs.
All pigs were anti-HEV seronegative by enzyme-linked immunosorbent assay
(ELISA) and free of HEV in feces by swine HEV-specific nested RT-PCR.
Three pigs served as uninoculated controls. Four positive-control pigs were
inoculated intravenously with the prototype U.S. swine strain (24). Four groups
of three pigs each were inoculated with 25 ml of either an HEV-positive pit or
lagoon sample via the intravenous or oral route. The selected lagoon sample was
collected from farm no. 19 and designated L19, and the selected pit sample was
collected from farm no. 12 and designated P12.
For preparation of the inocula, portions (150 ml) of the manure slurry col-
lected from L19 or P12 were dissolved in sterile DEPC water-based PBS to
produce a manure slurry suspension. The suspensions were clarified at 1,100 
g for 10 min at 4°C. Each pig was given 25 ml of the supernatant by intravenous
(i.v.) inoculation. Due to volume limitations, the intravenous inoculation was
performed for 5 consecutive days using 5 ml of the inocula per pig per day. The
accumulative HEV titer each pig received by intravenous inoculation was ap-
proximately 10 and 103 GE for L19 and P12, respectively. For oral inoculation,
25 ml of pooled pig manure slurry from L19 or P12 was given to naive pigs all at
one time by oral gavage. The HEV titer each pig received for oral inoculation
was approximately 10 and 103 GE for L19 and P12, respectively. Serum samples
and fecal swabs were collected weekly for anti-HEV serum antibodies and
detection of HEV RNA. The bioassay was terminated on 56 days postinocu-
lation (dpi).
Detection of anti-HEV immunoglobulin G antibodies by ELISA. Serum sam-
ples were tested by an ELISA using a purified 55-kDa truncated recombinant
putative capsid protein of human HEV Sar-55 strain as the antigen (24, 25). Each
serum sample was tested in duplicate, and mean optical density values above 0.3
were regarded as positive samples. Preimmune and hyperimmune sera were used
as negative and positive controls, respectively.
RESULTS
Detection of HEV in feces, manure slurry, and water sam-
ples. HEV RNA was detected in pooled fresh feces from 7 of
the 28 farms. Fifteen of 22 farms were found to have HEV-
positive manure slurry samples collected from concrete storage
pits. Three of 8 lagoons were positive for HEV RNA (Table 1).
The highest virus titer in manure slurry samples that tested
positive for HEV RNA was approximately 10 and 103 GE in
L19 and P12, respectively (Table 1).
The swine HEV-spiked water was concentrated to deter-
mine the efficacy of the concentration process and was tested
by swine HEV-specific RT-PCR assay and found to be positive
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for swine HEV RNA. However, none of the concentrated
water samples collected from on-site drinking water supplies or
the nearest surface water sources (creeks, streams, or rivers)
were positive for HEV RNA (data not shown).
Genetic variation of HEV isolates in pooled feces and pit or
lagoon manure slurry samples. Of 7 pooled fecal samples
positive for HEV RNA, nucleotide sequence analyses of the
amplicons revealed that the 7 HEV isolates shared 88 to 94%
identity with each other and 88 to 96% identity with the pro-
totype U.S. swine HEV. A phylogenetic tree was built based on
222-bp-long sequences. Phylogenetic analysis indicates that
HEVs amplified from feces or manure slurry samples collected
from either pit or lagoon facilities are segregated within geno-
type 3, which is where the prototype swine HEV and the US-2
strain of human HEV are clustered (Fig. 1). There were two
farms (farm no. 18 and 19) where the HEVs found in pig feces
and the pit or lagoon manure slurry samples were more closely
related to each other than to the HEVs from different farms.
On one farm (F18 and P18), the HEVs from feces and pit
manure slurry were identical (Fig. 1).
Determination of infectivity of HEV found in manure slurry
samples. The swine bioassay results are summarized in Table 2.
All positive-control pigs shed HEV in feces from 14 to 49 dpi,
and 3 of 4 positive-control pigs developed anti-HEV antibodies
by 56 dpi. Uninoculated control pigs remained HEV-free in
feces and negative for anti-HEV immunoglobulin G antibodies
by the termination of the study at 56 dpi. Two pigs inoculated
intravenously with the P12 inocula became infected with swine
FIG. 1. A phylogenetic tree based on analysis of a 222-bp nucleotide sequence of a portion of the ORF2 gene of HEV. Representative HEV
strains of 4 major genotypes (sar55, human HEV Pakistan strain [genotype 1]; Mexican, human HEV Mexican strain [genotype 2]; USsHEV,
prototype swine HEV strain [genotype 3]; hUS2, human HEV U.S. strain [genotype 3]; hHEVT1, Chinese human HEV T1 strain [genotype 4])
and a recently classified avian HEV strain were included in the analysis. F, P, and L represent HEV sequences amplified from pooled fecal, pit,
and lagoon samples, respectively, which are presented in Table 1. The number following the sample initial refers to the farm identification listed
in Table 1. A scale bar reflecting the numbers of character state changes is provided for comparison of genetic distance.
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HEV. The presence of HEV RNA in feces was detected in one
pig in the P12-inoculated group by 14 dpi and in the other pig
by 21 dpi. Both pigs continued to shed HEV in feces through
28 dpi. The pig that shed HEV in feces from 14 to 28 dpi
seroconverted to HEV, whereas the other pig remained sero-
negative on termination of the study at 56 dpi (Table 2). One
of 3 pigs inoculated intravenously with manure slurry from L19
developed anti-HEV antibodies by 56 dpi (Table 2). The am-
plicon of HEV RNA from feces collected at 21 dpi from a pig
(designated pig I) inoculated intravenously with P12 was 100%
identical to the amplicon of HEV RNA from the P12 intrave-
nous inoculum that the pig received. The amplicon of HEV
RNA from feces collected at 21 dpi from the other pig (des-
ignated pig II) in the P12 intravenous group was 93% identical
to the P12 intravenous inoculum that the pig received.
DISCUSSION
Fifteen of 22 farms (68%) were found to have HEV-positive
manure slurry samples. The concentration protocols used in
this study for detection of HEV in manure slurry offer a reli-
able method to detect small amounts of HEV RNA in large
volumes of manure slurry. In contrast, only 6 of the 15 farms
(40%) also had detectable HEV RNA in pooled fresh fecal
samples. This might be due to the low numbers (5 pigs) of
individual pigs sampled at each time point or due to RT-PCR
inhibitors that might have been present in the feces. An inter-
nal control for determination of the presence of RT-PCR
inhibitors could have been used to further confirm this but was
not part of our protocol at that time.
In the present study, all manure slurry samples were col-
lected during the late summer and autumn months of a year
when the ambient temperatures were quite warm compared to
those in the winter months in the Midwestern United States.
The high ambient temperatures at the time the manure slurry
samples were collected could have enhanced the biodegrada-
tion of organic waste in the manure slurry storage facilities and
decreased the amounts of HEV nucleic acids detectable by
RT-PCR and the viability of the virus assayed. In contrast, low
temperatures during winter months may preserve the infectiv-
ity of viruses in environmental samples for longer periods (5).
The HEV isolates from the pooled feces and manure slurry
were genetically diverse but all clustered in genotype 3 with the
prototype U.S. swine HEV. Nucleotide sequence comparison
showed that HEVs isolated from the pooled feces and pit
and/or lagoon samples of the same farm are genetically more
closely related to each other than those from different farms.
However, the HEV isolates from the pooled feces and manure
samples of farm no. 9 and 12 were more genetically distinct
than those of the other farms (Fig. 1). This may indicate mul-
tiple strains of HEV isolates circulating on one farm. It is
common to have growing pigs from more than one breeding
source present on a farm at the same time or over time. Wild
rats likely reside on pig farms. Therefore, it is also possible that
rats are an alternative source for contamination of pig manure
slurry storage facilities, since a high prevalence of anti-HEV
antibodies has been reported in wild rats (12, 14). Interestingly,
all HEVs found in the manure slurry samples tested in the
present study are phylogenetically clustered in genotype 3,
which is genetically distant from the rat HEV reported in
Nepal, which clusters in genotype 1 (12). Wild deer may also
gain access to manure slurry in lagoons in the Midwestern
United States. Since evidence of food-borne zoonotic trans-
mission of HEV from deer to humans has been reported in
Japan (33), it is reasonable to speculate that wild deer may be
another reservoir for HEV. To date, the status of anti-HEV
antibodies in wild deer has not been reported in the United
States. It remains to be determined whether HEV exists in the
U.S. wild deer populations and if deer may contribute to con-
tamination of the environment with HEV and subsequent
HEV transmission to humans, pigs, and other animals.
The swine bioassay indicates that HEV found in pig manure
slurry was infectious to naive pigs when inoculated intravenously
but not when inoculated orally. Intravenous inoculation is com-
monly done in HEV studies, and it has been shown previously
that HEV shed from pigs inoculated intravenously was infectious
to naive contact pigs (16, 23). Experimental studies indicate that
fecal-oral transmission of HEV in pigs may occur; however, it
likely requires a higher dose and repeated exposure for successful
transmission (16, 17). The results of this study are consistent with
the previous findings that experimental oral inoculation is less
efficient and requires a higher virus load to induce HEV infection
compared to intravenous inoculation (8, 17), since none of the 6
pigs inoculated orally became infected, whereas 2 of 6 pigs inoc-
ulated intravenously shed detectable amounts of HEV in feces.
However, it needs to be noted that, although all pigs received the
same total amount of inoculum, oral inoculation was only done
once. Intravenous inoculation was done on 5 consecutive days to
TABLE 2. Swine bioassay results: detection of HEV RNA in feces and anti-HEV serum antibodies
in pigs inoculated with manure slurry samples
Inoculum (titer as
genome equivalent) Route
No. of HEV RNA-positive pigs at each dpi anti-HEV (56 dpi)
0 a 7 14 21 28 35 42 49 56 Incidence b ELISA OD c
None (uninoculated) 0/3 b 0/3 0/3 NT d NT NT NT NT 0/3 0/3
L19 (10) Oral 0/3 0/3 0/3 0/3 0/3 0/3 NT NT 0/3 0/3
L19 (10) i.v. 0/3 0/3 0/3 0/3 0/3 0/3 NT NT 0/3 1/3 0.414
P12 (103) Oral 0/3 0/3 0/3 0/3 0/3 0/3 0/3 NT 0/3 0/3
P12 (103) i.v. 0/3 0/3 1/3 2/3 2/3 0/3 0/3 NT 0/3 1/3 0.306
Positive control (106) i.v. 0/4 3/4 4/4 4/4 4/4 4/4 4/4 4/4 0/4 3/4 0.425–1.269
a Fecal samples were collected at 0 to 56 days post inoculation.
b Number of pigs positive/number of pigs tested.
c Optical density (OD) of the positive samples; cutoff  0.3.
d NT, not tested.
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reduce the risk of adverse reactions from giving large volumes of
fecal material i.v. It is possible that the frequency of inoculation (1
inoculation versus 5 inoculations) influenced the results.
It has been demonstrated that HEV titers are typically
higher in feces than in blood (16). Because of this knowledge,
and the additional cost of testing, viremia was not test for or
confirmed in the present study. One pig inoculated intrave-
nously with the L19 inoculum seroconverted to HEV by 56 dpi
without detectable shedding of the virus in feces (Table 2). A
possible explanation for this discrepancy may be that the pig
did become infected and had brief localized replication of
HEV in the intestines (35) and that viremia and virus shedding
in feces may have been intermittent and undetected by weekly
RT-PCR testing. An alternative explanation is that the virus in
the L19 intravenous inoculum was able to induce an immune
response in that particular pig; however, as the swine bioassay
results indicate, the virus titer of 10 GE failed to induce HEV
infection. It has been demonstrated that the effective titer to
induce HEV infection, replication, and virus shedding in feces
in pigs was 102 GE when inoculated intravenously (17).
One pig from the positive control group and one pig from
the P12 intravenously inoculated (pig I) group had detectable
shedding of HEV in feces, yet they remained HEV seronega-
tive at the end of the study (Table 2). It has been previously
demonstrated that a small proportion of pigs experimentally
inoculated intravenously with swine HEV may have a delayed
response to the infection and that development of anti-HEV
antibodies may occur after the 56-day duration of the experi-
ment (17, 25).
Partial nucleotide sequences of the PCR amplicon amplified
from the P12 inocula and from 1 of the pigs (pig I) inoculated
intravenously with the P12 inocula were identical and were dif-
ferent from the amplicon amplified from the positive-control pigs
inoculated intravenously with the prototype swine HEV. This
confirms that the virus found in the P12 inocula was infectious,
replicated in pig I, and subsequently shed in the feces of that pig.
The lack of complete nucleotide identity between the virus found
in feces from pig II and the P12 inocula (and pig I) may reflect the
genetic variability of different HEVs (HEV quasispecies) found in
the manure slurry, since the amplicon from feces collected from
pig II was different from that in the P12 manure slurry or the
prototype swine HEV.
The swine bioassay findings are in accordance with a report
of analysis in raw sewage from an urban area in Spain where
HEV present in the biological waste facilities remained infec-
tious to experimentally inoculated rhesus monkeys (27). Sub-
sequently, the authors reported the presence of HEV in raw
sewage from pig slaughterhouses. However, an animal bioassay
was not performed to determine the infectivity of the HEV
found in the raw pig sewage (28). HEV has recently been
found in raw human sewage collected from industrialized
countries, including the United States. According to partial
nucleotide sequence analysis, the HEV found in the human
sewage was more homologous to the prototype U.S. swine
HEV than to the US-1 and US-2 strains of human HEV
(98.4% versus 91.0%) (6).
HEV was not found in the drinking or surface water samples
tested with the concentration methods used in the present
study. The methods used in the current study were able to
detect HEV in spiked water at a titer of 102 GE per ml water.
The dilution of the concentrated water samples with sterile
PBS and the extraction protocols using the microspin column
technique have been reported to minimize the inhibition of
PCR by potential inhibitors that have contaminated samples
prior to PCR (2, 34). It is, therefore, possible that either the
water samples tested in the study lacked HEV particles or the
level of contamination by HEV was below the detection ability
of the concentration methods applied in the study. It also
needs to be noted that sampling was done only at one time
point, thus not accounting for any seasonal effects, such as
recent rainfall, that may increase the amount of fecal material
in water. Colder weather may also better preserve virus. To
conclude that HEV is not present in water samples, more
samples collected over time and during various seasonal con-
ditions will need to be tested.
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